Skip to main content

Blog

Asthma and Allergy Research With You as an Equal Partner

The Asthma and Allergy Foundation of America (AAFA) conducts and promotes patient-centered research to help you. This means your beliefs, preferences and needs are at the center of our research. Your input drives our advocacy work, guides our education programs and supports our community. Recently, we’ve studied the following topics: Symptoms of anaphylaxis in infants and toddlers Eczema burdens and people’s experiences with treatments Impact of COVID-19 on people with asthma and allergy Air...

COVID-19 Impacts on People With Asthma and Allergies

Due to the coronavirus pandemic , families face uncertainty related to health, finances and overall well-being. The Asthma and Allergy Foundation of America (AAFA) surveyed 2,695 people to understand the impact of COVID-19 on asthma and allergy communities. The survey revealed the reach of the virus, how families are protecting themselves and the challenges families face specific to asthma and allergies. AAFA will use the results to target communication, education and advocacy efforts. Of...

Healthline Names AAFA Blog as One of the Best Blogs on Asthma for 2020

We are honored that the Asthma and Allergy Foundation of America’s blog has again been named one of the best asthma blogs by Healthline for 2020! Healthline is a health site with information on many health topics. We have received this honor since 2015 when we started our blog! Comment below to tell us what you want to see more of on our blog. We could not have received this honor without all of our supporters and members. Our blog will continue to bring you information about asthma and...

FDA Approves Dupixent® (Dupilumab) for Children Aged 6 to 11 Years With Moderate-to-Severe Atopic Dermatitis

The U.S. Food and Drug Administration (FDA) approved Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent is the only biologic medicine approved for this patient population.

Letter to the FDA: Require Food Manufacturers to Post Substitutions

On May 22, 2020, the Food and Drug Administration (FDA) relaxed labeling guidelines for food companies . This is a temporary measure because of food supply issues due to COVID-19 (the new coronavirus). The Asthma and Allergy Foundation of America (AAFA) met with the FDA to talk about how this will affect the food allergy community. After the meeting, we organized a joint letter with other food allergy advocacy organizations to send to the FDA. The letter addresses the FDA’s short-term food...

Carry Your Emergency Medicines Everywhere You Go When You Have Asthma and Allergies

The Asthma and Allergy Foundation of America (AAFA) and MedicAlert have teamed up to help you manage your asthma and allergies prevent life-threatening emergencies. Make a pact to “ACT” to manage your asthma and allergies: “A” means have an action plan for asthma or anaphylaxis . “C” reminds you to carry emergency medicines and wear a medical ID to alert others of your condition. “T” calls for having a treatment plan that includes when to take your medicines and what to do in an emergency.

What to Do If You Can't Afford Your Asthma Medicines

Keeping your asthma under control is a key part of staying healthy. Avoiding asthma triggers to prevent symptoms is important. So is carrying a quick-relief (rescue) inhaler everywhere you go. Long-term control medicines that you take every day help you prevent and control asthma symptoms. But asthma medicine can be expensive, whether or not you have insurance. If multiple members of your family have asthma, the cost is even greater. Your house may be stocked with different kinds of inhalers...

Congress Recognizes May as National Asthma and Allergy Awareness Month

The U.S. House of Representatives has declared their support for National Asthma and Allergy Awareness Month . Reps. Eliot Engel (D-NY), Fred Upton (R-MI), TJ Cox (D-CA) and Peter King (R-NY) submitted the resolution to the House Committee on Energy and Commerce on May 8, 2020. May is peak season for people with asthma and allergies. That’s why the Asthma and Allergy Foundation of America (AAFA) chose it as a time to raise awareness and educate people on how to manage these conditions. Read...

Join Our Twitter Chat to Learn How to Take Control of Your Asthma Health

Join the Asthma and Allergy Foundation of America (AAFA) and the American Academy of Allergy, Asthma & Immunology (AAAAI) on Thursday, May 21, 2020, at noon ET for a Twitter chat on how to take control of your asthma health. Follow @AAFAnational and @AAAAI_org and use the hashtag # asthmahealth to join the conversation. AAFA, AAAAI and other experts will answer questions about: What are common asthma symptoms? How is asthma diagnosed? What are common asthma triggers? What are some ways...

How an Action Plan Can Help You Treat Asthma and Allergic Reactions

The Asthma and Allergy Foundation of America (AAFA) and MedicAlert have teamed up to help you manage your asthma and allergies prevent life-threatening emergencies. Make a pact to “ACT” to manage your asthma and allergies: “A” means have an action plan for asthma or anaphylaxis. “C” reminds you to carry emergency medicines and wear a medical ID to alert others of your condition. “T” calls for having a treatment plan that includes when to take your medicines and what to do in an emergency.

Easy Ways to Raise Awareness About Asthma and Allergies

Help us raise awareness about asthma and allergies during May, National Asthma and Allergy Awareness Month with 31 Days of Action . About 25 million people in the U.S. (20 million adults and 5 million children) have asthma. And around 32 million Americans (26 million adults and 6 million children) have food allergies. Asthma alone causes 1.6 million emergency department visits each year. And severe allergic reactions to food cause 30,000 emergency department visits. With the right education...

Post
×
×
×
×